IE36854B1 - Anaesthetic compositions - Google Patents

Anaesthetic compositions

Info

Publication number
IE36854B1
IE36854B1 IE1597/71A IE159771A IE36854B1 IE 36854 B1 IE36854 B1 IE 36854B1 IE 1597/71 A IE1597/71 A IE 1597/71A IE 159771 A IE159771 A IE 159771A IE 36854 B1 IE36854 B1 IE 36854B1
Authority
IE
Ireland
Prior art keywords
pregnane
dione
solution
recovered
hydroxy
Prior art date
Application number
IE1597/71A
Other languages
English (en)
Other versions
IE36854L (en
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of IE36854L publication Critical patent/IE36854L/xx
Publication of IE36854B1 publication Critical patent/IE36854B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Steroid Compounds (AREA)
IE1597/71A 1970-12-17 1971-12-16 Anaesthetic compositions IE36854B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6006970A GB1380247A (en) 1970-12-17 1970-12-17 Anaesthetic compositions

Publications (2)

Publication Number Publication Date
IE36854L IE36854L (en) 1972-06-17
IE36854B1 true IE36854B1 (en) 1977-03-16

Family

ID=10484953

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1597/71A IE36854B1 (en) 1970-12-17 1971-12-16 Anaesthetic compositions

Country Status (9)

Country Link
AU (1) AU473308B2 (enExample)
BE (1) BE776790A (enExample)
CA (1) CA975682A (enExample)
DE (1) DE2162591A1 (enExample)
FR (1) FR2118122B1 (enExample)
GB (1) GB1380247A (enExample)
IE (1) IE36854B1 (enExample)
NL (1) NL7117309A (enExample)
ZA (1) ZA718467B (enExample)

Also Published As

Publication number Publication date
CA975682A (en) 1975-10-07
AU473308B2 (en) 1976-06-17
FR2118122B1 (enExample) 1975-12-26
DE2162591A1 (de) 1972-07-06
IE36854L (en) 1972-06-17
NL7117309A (enExample) 1972-06-20
FR2118122A1 (enExample) 1972-07-28
GB1380247A (en) 1975-01-08
ZA718467B (en) 1973-08-29
AU3696371A (en) 1973-06-21
BE776790A (fr) 1972-06-16

Similar Documents

Publication Publication Date Title
NL7701427A (nl) Werkwijze voor de scheiding van stoffen door gefractioneerde kristallisatie uit een vloei- baar mengsel.
US2773080A (en) delta-pregnenes
YU40476A (en) Process for the separation of the organic substance from blood
NL277685A (nl) Werkwijze voor de gelijktijdige winning van zuiver ammoniumsulfaat en zuvere lactamen uit omzettingsmengsels val alicyclische ketoximen
CA1015143A (en) Method of attaching resilient liners to steel structures
IE36854B1 (en) Anaesthetic compositions
JPS5263896A (en) Recovery process for valuable component of sulfur from waste sulfuric acid
US2867633A (en) 11-oxygenated-6-methyl-17alpha-hydroxy-4-pregnene-3, 20-diones
AT306049B (de) Verfahren zur Herstellung von neuen Carbamoyl-oximen
BE816373A (fr) Procede de traitement d'esters bruts
YU340774A (en) Process for the isolation of crude lead from sulfidic
US2867631A (en) 6-methylated and 11-oxygenated-17 alpha-hydroxy-21-fluoro 4-pregnene 3, 20 diones
AU484156B2 (en) Process forthe separation of diene from organic mixtures
ES408023A1 (es) Un procedimiento para la preparacion de nuevos derivados decefalesperina y penicilina.
US3019244A (en) 11alpha-allylated 11beta-hydroxy-5beta-pregnane-3, 20-dione bisoximes and process
US3019243A (en) 11beta-hydroxy-5beta-pregnane-3, 20-dione bisoximes and the 11alpha-lower-alkyl derivatives thereof
BE778942A (fr) Procede de separation des constituants d'un melange de polyisocyanates organiques
US2897198A (en) 11alpha-alkene-11beta-hydroxy-5beta-pregnanes
US2808415A (en) Delta4, 8(9)-3, 20-diketo-11, 17-dihydroxy-21-oxygenated-pregnadienes and processes of preparing the same
US3054812A (en) 20beta, 21-dinitrato-delta4-pregnene-17alpha-ol-3, 11-dione, its production, and method of use
GB1444154A (en) 15alpha, 16alpha-delta4-pregnenes
US3463775A (en) 17alpha-methyl-retrosteroids
CA959071A (en) Process for the separation and recovery of methylterephthalic acid and 4-methylisophthalic acid from a mixture thereof
FR1278267A (fr) Procédé de production d'acétate de butyle tertiaire
US3080391A (en) 6alpha-chloro-delta1, 4-androstadien-17beta-ol-3-one derivatives